Back
Guangzhou Innogen Pharmaceutical Group Co., Ltd (02591.HK) Price
02591.HK Stock Price Chart
INNOGEN-B (02591.HK)
Guangzhou Innogen Pharmaceutical Group Co., Ltd
HK$27.6
2.14%
$0.58
CLOSED_MARKET: Feb 13, 16:00:00 HKT
Key Stats
Prev.Close
$27.34
Open
$27.02
Day's Range
$27.02 - $27.84
52 week range
$25.5 - $74
Volume
162.8K
Avg.Volume
1.0M
EPS (TTM)
-0.55
Dividend yield
--
Market Cap
$11.5B
What is INNOGEN-B?
Guangzhou Innogen Pharmaceutical Group Co., Ltd. engages in the production and distribution of pharmaceutical products. The company is headquartered in Guangzhou, Guangdong and currently employs 105 full-time employees. The company went IPO on 2025-08-15. The firm is primarily engaged in the commercialization of innovative, humanized, long-acting glucagon-like peptide-1 (GLP-1) receptor agonist. The firm is dedicated to developing therapies for diabetes and other metabolic diseases. The Company’s core product, Efsubaglutide Alfa (brand name: Diabegone), is used for the treatment of type 2 diabetes (T2D). The Company’s primary pipeline drug candidates include YN014, YN401, YN209, YN203, and YN202. The firm principally conducts its businesses in the domestic market.
Features
Resources
© 2026 Finture Development Limited. All rights reserved
